/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Optimal pharmacotherapy
Event: EuroThrombosis and EuroVessels 2022
Topic: Thrombosis, Bleeding
Session: Lower Extremity Artery Disease: improved management for better outcome
Assessment of arterial damage in vascular Ehlers-Danlos syndrome: a retrospective multicentric cohort
Event: ESC Congress 2022
Topic: Peripheral Artery Disease
Session: Peripheral artery disease, COVID and rare vascular diseases
Celiprolol to prevent arterial events in patients with vascular Ehlers-Danlos and neither symptomatic nor silent arterial event. A retrospective cohort study from the French national reference center
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Medical management and risk factors
Characteristics of upper limb arterial involvement in thromboangeiitis obliterans patients
Event: ESC Congress 2018
Topic: Peripheral Artery Disease
Session: Peripheral artery disease: clinical
Efficacy and potency of revascularisation in patients with thromboangiitis obliterans (Buerger disease)
Event: ESC Congress 2017
Topic: Peripheral arterial disease
Session: Vascular diseases - 1
ESC 365 is supported by
